Tumor necrosis factor gene polymorphisms and clearance or progression of hepatitis B virus infection

Grazia Anna Niro, Rosanna Fontana, Domenica Gioffreda, Maria Rosa Valvano, Angelo Lacobellis, Domenico Facciorusso, Angelo Andriulli

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Objectives: We evaluated the influence of tumor necrosis factor-α (TNF-α) promoter gene polymorphisms on clearance of hepatitis B virus (HBV) and outcome of HBV chronic hepatitis. Methods: Four TNF-α promoter polymorphisms (T-1031C, C-863A, G-308A, and G-238A) were evaluated by direct sequencing in 184 chronic HBV carriers hepatitis B surface antigen (HBsAg) positive and 96 controls with documented seroclearance (HBsAg negativity, positivity for anti-HBs and anti-HBc IgG). Frequencies of single-nucleotide polymorphisms (SNPs) and haplotypes in the control group were compared with those of the chronic carrier group and with clinically defined subgroups of the latter: asymptomatic carriers, patients with compensated hepatitis, decompensated cirrhotics, and patients with hepatocellular carcinoma. Furthermore, subgroups of chronic carriers were compared among them. Results: In the chronic carrier group, the - 308G allele was more frequent in those with a family history of HBV infection (96% vs 88% of those with non-familial transmission). The G/G genotype at position - 308 was found in all chronic carriers with decompensated cirrhosis but in only 78% of controls (P = 0.01) and was more frequent in decompensated cirrhotics than in the other subgroups. The distribution of TNF-α gene polymorphisms in the carrier group was not significantly different from that in the sero-clearance control group. TNF-α SNPs at positions - 1031/ - 863 and - 863/ - 238 were in linkage disequilibrium. The TCGG haplotype (- T1031, - C863, - G308, - G238) was significantly associated with end-stage liver disease. Conclusion: The TNF-α promoter polymorphisms do not appear to be determinant of HBV seroclearance in southern Italians. The genotype - 308G/G and haplotype TCGG are associated with an unfavorable prognosis in patients with chronic HBV infection.

Original languageEnglish
Pages (from-to)1175-1181
Number of pages7
JournalLiver International
Volume25
Issue number6
DOIs
Publication statusPublished - Dec 2005

Fingerprint

Virus Diseases
Hepatitis B virus
Tumor Necrosis Factor-alpha
Haplotypes
Genes
Chronic Hepatitis B
Hepatitis B Surface Antigens
Single Nucleotide Polymorphism
Genotype
Control Groups
End Stage Liver Disease
Linkage Disequilibrium
Chronic Hepatitis
Hepatitis
Hepatocellular Carcinoma
Fibrosis
Alleles

Keywords

  • Chronic hepatitis
  • Cirrhosis
  • Haplotypes
  • HBV
  • HCC
  • TNF-α polymorphisms

ASJC Scopus subject areas

  • Hepatology

Cite this

Tumor necrosis factor gene polymorphisms and clearance or progression of hepatitis B virus infection. / Niro, Grazia Anna; Fontana, Rosanna; Gioffreda, Domenica; Valvano, Maria Rosa; Lacobellis, Angelo; Facciorusso, Domenico; Andriulli, Angelo.

In: Liver International, Vol. 25, No. 6, 12.2005, p. 1175-1181.

Research output: Contribution to journalArticle

Niro, Grazia Anna ; Fontana, Rosanna ; Gioffreda, Domenica ; Valvano, Maria Rosa ; Lacobellis, Angelo ; Facciorusso, Domenico ; Andriulli, Angelo. / Tumor necrosis factor gene polymorphisms and clearance or progression of hepatitis B virus infection. In: Liver International. 2005 ; Vol. 25, No. 6. pp. 1175-1181.
@article{9ea50d2234164dad8f0e4ba1bdf18c70,
title = "Tumor necrosis factor gene polymorphisms and clearance or progression of hepatitis B virus infection",
abstract = "Objectives: We evaluated the influence of tumor necrosis factor-α (TNF-α) promoter gene polymorphisms on clearance of hepatitis B virus (HBV) and outcome of HBV chronic hepatitis. Methods: Four TNF-α promoter polymorphisms (T-1031C, C-863A, G-308A, and G-238A) were evaluated by direct sequencing in 184 chronic HBV carriers hepatitis B surface antigen (HBsAg) positive and 96 controls with documented seroclearance (HBsAg negativity, positivity for anti-HBs and anti-HBc IgG). Frequencies of single-nucleotide polymorphisms (SNPs) and haplotypes in the control group were compared with those of the chronic carrier group and with clinically defined subgroups of the latter: asymptomatic carriers, patients with compensated hepatitis, decompensated cirrhotics, and patients with hepatocellular carcinoma. Furthermore, subgroups of chronic carriers were compared among them. Results: In the chronic carrier group, the - 308G allele was more frequent in those with a family history of HBV infection (96{\%} vs 88{\%} of those with non-familial transmission). The G/G genotype at position - 308 was found in all chronic carriers with decompensated cirrhosis but in only 78{\%} of controls (P = 0.01) and was more frequent in decompensated cirrhotics than in the other subgroups. The distribution of TNF-α gene polymorphisms in the carrier group was not significantly different from that in the sero-clearance control group. TNF-α SNPs at positions - 1031/ - 863 and - 863/ - 238 were in linkage disequilibrium. The TCGG haplotype (- T1031, - C863, - G308, - G238) was significantly associated with end-stage liver disease. Conclusion: The TNF-α promoter polymorphisms do not appear to be determinant of HBV seroclearance in southern Italians. The genotype - 308G/G and haplotype TCGG are associated with an unfavorable prognosis in patients with chronic HBV infection.",
keywords = "Chronic hepatitis, Cirrhosis, Haplotypes, HBV, HCC, TNF-α polymorphisms",
author = "Niro, {Grazia Anna} and Rosanna Fontana and Domenica Gioffreda and Valvano, {Maria Rosa} and Angelo Lacobellis and Domenico Facciorusso and Angelo Andriulli",
year = "2005",
month = "12",
doi = "10.1111/j.1478-3231.2005.01166.x",
language = "English",
volume = "25",
pages = "1175--1181",
journal = "Liver International",
issn = "1478-3223",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "6",

}

TY - JOUR

T1 - Tumor necrosis factor gene polymorphisms and clearance or progression of hepatitis B virus infection

AU - Niro, Grazia Anna

AU - Fontana, Rosanna

AU - Gioffreda, Domenica

AU - Valvano, Maria Rosa

AU - Lacobellis, Angelo

AU - Facciorusso, Domenico

AU - Andriulli, Angelo

PY - 2005/12

Y1 - 2005/12

N2 - Objectives: We evaluated the influence of tumor necrosis factor-α (TNF-α) promoter gene polymorphisms on clearance of hepatitis B virus (HBV) and outcome of HBV chronic hepatitis. Methods: Four TNF-α promoter polymorphisms (T-1031C, C-863A, G-308A, and G-238A) were evaluated by direct sequencing in 184 chronic HBV carriers hepatitis B surface antigen (HBsAg) positive and 96 controls with documented seroclearance (HBsAg negativity, positivity for anti-HBs and anti-HBc IgG). Frequencies of single-nucleotide polymorphisms (SNPs) and haplotypes in the control group were compared with those of the chronic carrier group and with clinically defined subgroups of the latter: asymptomatic carriers, patients with compensated hepatitis, decompensated cirrhotics, and patients with hepatocellular carcinoma. Furthermore, subgroups of chronic carriers were compared among them. Results: In the chronic carrier group, the - 308G allele was more frequent in those with a family history of HBV infection (96% vs 88% of those with non-familial transmission). The G/G genotype at position - 308 was found in all chronic carriers with decompensated cirrhosis but in only 78% of controls (P = 0.01) and was more frequent in decompensated cirrhotics than in the other subgroups. The distribution of TNF-α gene polymorphisms in the carrier group was not significantly different from that in the sero-clearance control group. TNF-α SNPs at positions - 1031/ - 863 and - 863/ - 238 were in linkage disequilibrium. The TCGG haplotype (- T1031, - C863, - G308, - G238) was significantly associated with end-stage liver disease. Conclusion: The TNF-α promoter polymorphisms do not appear to be determinant of HBV seroclearance in southern Italians. The genotype - 308G/G and haplotype TCGG are associated with an unfavorable prognosis in patients with chronic HBV infection.

AB - Objectives: We evaluated the influence of tumor necrosis factor-α (TNF-α) promoter gene polymorphisms on clearance of hepatitis B virus (HBV) and outcome of HBV chronic hepatitis. Methods: Four TNF-α promoter polymorphisms (T-1031C, C-863A, G-308A, and G-238A) were evaluated by direct sequencing in 184 chronic HBV carriers hepatitis B surface antigen (HBsAg) positive and 96 controls with documented seroclearance (HBsAg negativity, positivity for anti-HBs and anti-HBc IgG). Frequencies of single-nucleotide polymorphisms (SNPs) and haplotypes in the control group were compared with those of the chronic carrier group and with clinically defined subgroups of the latter: asymptomatic carriers, patients with compensated hepatitis, decompensated cirrhotics, and patients with hepatocellular carcinoma. Furthermore, subgroups of chronic carriers were compared among them. Results: In the chronic carrier group, the - 308G allele was more frequent in those with a family history of HBV infection (96% vs 88% of those with non-familial transmission). The G/G genotype at position - 308 was found in all chronic carriers with decompensated cirrhosis but in only 78% of controls (P = 0.01) and was more frequent in decompensated cirrhotics than in the other subgroups. The distribution of TNF-α gene polymorphisms in the carrier group was not significantly different from that in the sero-clearance control group. TNF-α SNPs at positions - 1031/ - 863 and - 863/ - 238 were in linkage disequilibrium. The TCGG haplotype (- T1031, - C863, - G308, - G238) was significantly associated with end-stage liver disease. Conclusion: The TNF-α promoter polymorphisms do not appear to be determinant of HBV seroclearance in southern Italians. The genotype - 308G/G and haplotype TCGG are associated with an unfavorable prognosis in patients with chronic HBV infection.

KW - Chronic hepatitis

KW - Cirrhosis

KW - Haplotypes

KW - HBV

KW - HCC

KW - TNF-α polymorphisms

UR - http://www.scopus.com/inward/record.url?scp=28944453775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28944453775&partnerID=8YFLogxK

U2 - 10.1111/j.1478-3231.2005.01166.x

DO - 10.1111/j.1478-3231.2005.01166.x

M3 - Article

VL - 25

SP - 1175

EP - 1181

JO - Liver International

JF - Liver International

SN - 1478-3223

IS - 6

ER -